PGIM Jennison Health Sciences Fund - Class A (PHLAX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
32.23
-0.08 (-0.25%)
Jul 30, 2025, 4:00 PM EDT
-0.25%
Fund Assets1.36B
Expense Ratio1.13%
Min. Investment$1,000
Turnover79.00%
Dividend (ttm)5.31
Dividend Yield15.58%
Dividend Growth177.71%
Payout FrequencyAnnual
Ex-Dividend DateDec 20, 2024
Previous Close32.31
YTD Return-5.09%
1-Year Return-2.15%
5-Year Return47.37%
52-Week Low29.55
52-Week High43.93
Beta (5Y)n/a
Holdings45
Inception DateJun 30, 1999

About PHLAX

PGIM Jennison Health Sciences Fund Class A is a mutual fund focused on long-term capital appreciation by investing primarily in equity and equity-related securities of U.S. companies within the healthcare sector. The fund targets firms engaged in pharmaceuticals, biotechnology, medical equipment, hospitals, nursing care, and health insurance carriers. With assets totaling approximately $1.68 billion and an expense ratio of about 1.13%, it offers exposure to a diversified portfolio of around 46 holdings, including prominent healthcare companies such as Eli Lilly, UnitedHealth Group, and Bristol-Myers Squibb. Since its inception in 1999, the fund has sought to leverage healthcare innovation and growth trends to deliver value, making it a specialized vehicle within the health sciences investment space. The fund pays dividends annually and maintains a focus on large growth companies in the health sector.

Fund Family PGIM Investments
Category Health
Stock Exchange NASDAQ
Ticker Symbol PHLAX
Share Class Class A
Index S&P Composite 1500 Health Care TR

Performance

PHLAX had a total return of -2.15% in the past year, including dividends. Since the fund's inception, the average annual return has been 13.61%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

SymbolShare ClassExpense Ratio
PHLQXClass R60.77%
PHSZXClass Z0.86%
PJHRXClass R1.48%
PHLCXClass C1.96%

Top 10 Holdings

57.84% of assets
NameSymbolWeight
Eli Lilly and CompanyLLY14.60%
Prudential Govt Money Mkt Fdn/a10.96%
Vertex Pharmaceuticals IncorporatedVRTX4.95%
argenx SEARGX4.85%
Neurocrine Biosciences, Inc.NBIX4.78%
AstraZeneca PLCAZN4.64%
Thermo Fisher Scientific Inc.TMO3.58%
Novo Nordisk A/SNVO3.50%
Alnylam Pharmaceuticals, Inc.ALNY3.15%
UnitedHealth Group IncorporatedUNH2.85%

Dividend History

Ex-DividendAmountPay Date
Dec 20, 2024$5.31325Dec 20, 2024
Dec 20, 2023$1.91322Dec 20, 2023
Dec 20, 2022$0.61624Dec 20, 2022
Dec 20, 2021$14.02528Dec 20, 2021
Dec 20, 2019$1.43164Dec 20, 2019
Dec 20, 2018$4.77761Dec 20, 2018
Full Dividend History